SAT0203 Concomitant Methotrexate Scarcely Augment the Clinical Efficacy of Abatacept in Patients with Rheumatoid Arthritis: A Propensity Score Matching Analysis

N. Takahashi; T. Kojima; K. Funahashi; N. Ishiguro

doi:10.1136/annrheumdis-2015-eular.2121

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Poster Presentations

Rheumatoid arthritis - other biologic treatment

SAT0203 Concomitant Methotrexate Scarcely Augment the Clinical Efficacy of Abatacept in Patients with Rheumatoid Arthritis: A Propensity Score Matching Analysis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Takahashi N, Kojima T, Funahashi K on behalf of TBCR study group , et al

SAT0203 Concomitant Methotrexate Scarcely Augment the Clinical Efficacy of Abatacept in Patients with Rheumatoid Arthritis: A Propensity Score Matching Analysis

Annals of the Rheumatic Diseases 2015;74:729-730.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password